The Ensign Group (ENSG) Releases FY17 Earnings Guidance
The Ensign Group (NASDAQ:ENSG) issued an update on its FY17 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $1.80-1.87 for the period, compared to the Thomson Reuters consensus estimate of $1.40. The company issued revenue guidance of $2-2.06 billion, compared to the consensus revenue estimate of $1.80 billion.
The Ensign Group (ENSG) traded down $0.06 during trading hours on Thursday, hitting $23.57. 352,074 shares of the stock traded hands, compared to its average volume of 215,296. The Ensign Group has a one year low of $16.50 and a one year high of $24.78. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.53 and a current ratio of 1.53. The company has a market cap of $1,175.90, a price-to-earnings ratio of 26.19 and a beta of 0.81.
The Ensign Group (NASDAQ:ENSG) last announced its earnings results on Wednesday, November 8th. The company reported $0.33 EPS for the quarter, missing the consensus estimate of $0.35 by ($0.02). The Ensign Group had a return on equity of 13.15% and a net margin of 2.65%. The firm had revenue of $471.59 million during the quarter, compared to analyst estimates of $445.95 million. equities analysts forecast that The Ensign Group will post 1.28 earnings per share for the current year.
Several research analysts have commented on ENSG shares. Royal Bank of Canada reiterated a buy rating and issued a $21.00 target price on shares of The Ensign Group in a report on Tuesday, November 7th. Cantor Fitzgerald raised their target price on shares of The Ensign Group from $23.00 to $27.00 and gave the stock an overweight rating in a report on Thursday, November 9th. ValuEngine cut shares of The Ensign Group from a buy rating to a hold rating in a report on Tuesday, November 14th. Finally, BidaskClub cut shares of The Ensign Group from a buy rating to a hold rating in a report on Tuesday, December 5th. Three equities research analysts have rated the stock with a sell rating, one has given a hold rating and three have assigned a buy rating to the company. The company has a consensus rating of Hold and an average price target of $26.67.
In other news, VP Barry Port sold 10,000 shares of the stock in a transaction that occurred on Monday, November 20th. The shares were sold at an average price of $24.00, for a total value of $240,000.00. Following the completion of the sale, the vice president now directly owns 134,684 shares of the company’s stock, valued at $3,232,416. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Beverly B. Wittekind sold 5,000 shares of the stock in a transaction that occurred on Monday, December 11th. The stock was sold at an average price of $22.55, for a total transaction of $112,750.00. Following the completion of the sale, the vice president now directly owns 46,656 shares of the company’s stock, valued at $1,052,092.80. The disclosure for this sale can be found here. Over the last quarter, insiders sold 69,318 shares of company stock valued at $1,648,075. Corporate insiders own 6.20% of the company’s stock.
The Ensign Group Company Profile
The Ensign Group, Inc, through its operating subsidiaries, provides healthcare services across the post-acute care continuum, as well as other ancillary businesses located in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, Oregon, South Carolina, Texas, Utah, Washington and Wisconsin.
Receive News & Ratings for The Ensign Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Ensign Group and related companies with MarketBeat.com's FREE daily email newsletter.